These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6139839)

  • 21. Influence of classical and atypical neuroleptics on apomorphine-induced behavioural changes and on extinction of a conditioned avoidance response.
    Serra G; Van Ree JM; de Wied D
    J Pharm Pharmacol; 1983 Apr; 35(4):255-7. PubMed ID: 6133940
    [No Abstract]   [Full Text] [Related]  

  • 22. The hypomotility elicited by small doses of apomorphine seems exclusively mediated by dopaminergic systems in the nucleus accumbens.
    Radhakishun FS; Van Ree JM
    Eur J Pharmacol; 1987 May; 137(1):41-7. PubMed ID: 3609134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Yawning is elicited by D2 dopamine agonists but is blocked by the D1 antagonist, SCH 23390.
    Serra G; Collu M; Gessa GL
    Psychopharmacology (Berl); 1987; 91(3):330-3. PubMed ID: 2882540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apomorphine effect on single and paired rat open-field behavior.
    Arakawa O; Ikeda T
    Physiol Behav; 1991 Jul; 50(1):189-94. PubMed ID: 1946716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence that apomorphine and pergolide induce rotation in rats by different actions on D1 and D2 receptor sites.
    Herrera-Marschitz M; Ungerstedt U
    Eur J Pharmacol; 1984 Feb; 98(2):165-76. PubMed ID: 6143675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Locomotion and stereotyped behaviours induced by 1-amino-3,5-dimethyladamantane (D 145) and apomorphine in the rat: a comparison.
    Ljungberg T
    J Pharm Pharmacol; 1986 Jul; 38(7):520-5. PubMed ID: 2875153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atypical neuroleptics suppress dopaminergic behavioral supersensitivity.
    Schremmer C; Morgenstern R; Fink H; Ott T
    Psychopharmacology (Berl); 1990; 100(3):399-403. PubMed ID: 1969173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential ability of selective and non-selective dopamine agonists to induce climbing in the rat indicates the involvement of both D-1 and D-2 receptors in this behaviour.
    Davis A; Jenner P; Marsden CD
    Psychopharmacology (Berl); 1990; 100(1):19-26. PubMed ID: 1967499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential effects of continuous administration for 1 year of haloperidol or sulpiride on striatal dopamine function in the rat.
    Rupniak NM; Mann S; Hall MD; Fleminger S; Kilpatrick G; Jenner P; Marsden CD
    Psychopharmacology (Berl); 1984; 84(4):503-11. PubMed ID: 6441951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.
    Breese GR; Napier TC; Mueller RA
    J Pharmacol Exp Ther; 1985 Aug; 234(2):447-55. PubMed ID: 3926987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced stereotyped response to apomorphine after chronic D-1 blockade with SCH 23390.
    Vaccheri A; Dall'Olio R; Gandolfi O; Roncada P; Montanaro N
    Psychopharmacology (Berl); 1987; 91(3):394-6. PubMed ID: 2882541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences in effects of sultopride and sulpiride on dopamine turnover in rat brain.
    Moriuchi K; Imazu Y; Yoneda H
    Neurochem Res; 1995 Jan; 20(1):95-9. PubMed ID: 7739765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sulpiride injection into the dorsal striatum increases methamphetamine-induced gnawing in rats.
    Koshikawa N; Aoki S; Tomiyama K; Maruyama Y; Kobayashi M
    Eur J Pharmacol; 1987 Jan; 133(1):119-25. PubMed ID: 3556388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characteristics of the dopamine receptors involved in the anorectic effects of apomorphine in mice.
    Duterte-Boucher D; Naudin B; Costentin J
    Fundam Clin Pharmacol; 1989; 3(4):337-46. PubMed ID: 2553567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of drinking by naltrexone in the rat: interaction with the dopamine D-1 antagonist SCH 23390 and the D-2 antagonist sulpiride.
    Ukai M; Nakayama S; Kameyama T
    Pharmacol Biochem Behav; 1989 Mar; 32(3):651-5. PubMed ID: 2662222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-n-propyl-norapomorphine: an extremely potent stimulant of dopamine autoreceptors.
    Argiolas A; Mereu G; Serra G; Melis MR; Fadda F; Gessa GL
    Brain Res; 1982 Jan; 231(1):109-16. PubMed ID: 6799148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ventral tegmental area: site through which dopamine D2-receptor agonists evoke behavioural and electrocortical sleep in rats.
    Bagetta G; De Sarro G; Priolo E; Nisticò G
    Br J Pharmacol; 1988 Nov; 95(3):860-6. PubMed ID: 2974741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced apomorphine-induced sedation following chronic stress.
    Cancela LM; Molina VA
    Eur J Pharmacol; 1987 Jan; 134(1):117-9. PubMed ID: 3556397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sleep induced by low doses of apomorphine in rats.
    Mereu GP; Scarnati E; Paglietti E; Quarantotti BP; Chessa P; Di Chiara G; Gessa GL
    Electroencephalogr Clin Neurophysiol; 1979 Feb; 46(2):214-9. PubMed ID: 86429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antistereotypic effects of dopamine D-1 and D-2 antagonists after intrastriatal injection in rats. Pharmacological and regional specificity.
    Arnt J
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Aug; 330(2):97-104. PubMed ID: 2864641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.